Business Context and Reporting Period
Company: TriSalus Life Sciences, Inc. (TLSI)
Filing Type: Form 8-K (Current Report)
Date of Report: May 15, 2025
Reporting Period: Quarter ended March 31, 2025
Business Update: The Company issued a press release on May 15, 2025, providing a business update and announcing financial results for the quarter ended March 31, 2025. The full text of the press release is included as Exhibit 99.1.
Key Financial Metrics
The provided Form 8-K text serves as a cover document referencing a press release (Exhibit 99.1) for detailed financial data. The filing text itself does not contain specific numerical values for the following metrics:
- Revenue: Not provided in filing text.
- Profit/Loss: Not provided in filing text.
- Cash Flow: Not provided in filing text.
- Margins: Not provided in filing text.
- Debt and Liquidity: Not provided in filing text.
Material Changes
The filing text does not provide specific comparative data or details regarding material changes versus the prior comparable period. Investors must refer to Exhibit 99.1 for this analysis.
Guidance, Outlook, and Risks
Management Commentary: The Company announced a business update and financial results via press release. Specific commentary, guidance, or outlook details are contained within Exhibit 99.1 and are not summarized in the 8-K body text.
Risks and Contingencies: No specific risks or contingencies are detailed in the provided text. The filing includes a standard disclaimer that the information in Item 2.02 and Exhibit 99.1 is "furnished" and not "filed" for purposes of Section 18 of the Exchange Act, limiting liability.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated May 15, 2025) for actual revenue, net income, and cash flow figures for the quarter ended March 31, 2025.
- Verify the Company's status as an Emerging Growth Company (indicated as "x" in the filing) and its election regarding extended transition periods for accounting standards.
- Confirm the trading status of Common Stock (TLSI) and Warrants (TLSIW) on the Nasdaq Global Market.
- Check for any forward-looking statements in the press release that may differ from historical performance.